Tolvaptan
Vaptans for the Treatment of Hyponatremia in Heart Failure - YouTube
Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure | Future Cardiology
Arginine Vasopressin Antagonists for the Treatment of Heart Failure and Hyponatremia | Circulation
Tolvaptan mechanism of action in ADPKD
SAMSCA® (tolvaptan) Mechanism of Action
Mechanism of Action | HCP JYNARQUE® (tolvaptan) tablets
Tolvaptan Tablets for Hyponatremia are now FDA Approved | Uremic Frost
Tolvaptan
Homepage | SAMSCA® (tolvaptan)
SAMSCA® (tolvaptan) Mechanism of Action
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan | American Society of Nephrology
Tolvaptan
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan | American Society of Nephrology
Concurrent diuretic therapy with tolvaptan administration | Download Table
Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects | Molecular Medicine | Full Text
Tolvaptan, a vasopressin V2 receptor antagonist, is a strong diuretic with a new mechanism of action - YouTube
Tolvaptan | C26H25ClN2O3 - PubChem
Update on ADPKD and role of mTOR inhibitors and other agents in its management. - ppt download
HYPONATREMIA AND THE EMERGING ROLE OF TOLVAPTAN IN CARDIOLOGY - ppt download
Role of tolvaptan in the management of hyponatremia in patients with l | CMAR
Impact of continued administration of tolvaptan on cirrhotic patients with ascites | BMC Pharmacology and Toxicology | Full Text
HYPONATREMIA AND TREATMENT WITH TOLVAPTAN UZMA MEHDI M
